Back to search results

Study With [225Ac]Ac-FL-020 in mCRPC Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Metastatic Castration-resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Jennifer Simpson)
    Contact: Principal Investigator (Jeffrey Wong, MD)

  • Chao Family Comprehensive Cancer Center, Irvine, California, United States

    Contact: Study coordinator (Amanda Macaraeg) · macaraeg@hs.uci.edu · 714-456-8000
    Contact: Principal Investigator (Shyam Srinivas, MD)

  • University of Stanford, Stanford, California, United States

    Contact: Study coordinator (David G. Marcellus)
    Contact: Principal Investigator (Andrei Iagaru, MD)
    Contact: Principal Investigator (Hong Song, MD)

  • University Hospital of Cleveland, Cleveland, Ohio, United States

    Contact: Study coordinator (Cheryl L Eitman, Clinical research Nurse) · cheryl.eitman2@uhhospitals.org · +1 216 392-6512
    Contact: Principal Investigator (Pedro Barata, MD)

  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Robert Dreicer, Principal Investigator) · rd7va@UVAHealth.org · +1 434-924-1775
    Contact: Study coordinator (Christine P Martin, Clinical Trial Coordinator) · cmp2p@uvahealth.org

  • Princess Alexandra Hospital, Brisbane, Australia

    Contact: Study coordinator (Gillian Jagger)
    Contact: Principal Investigator (Aaron Hansen, MD)

  • Genesiscare Murdoch, Murdoch, Australia

    Contact: Study coordinator (Vicki Sproule)
    Contact: Principal Investigator (Joe Cardaci, MD)

  • MacQuarie University Clinical Trial Unit, Sydney, Australia

    Contact: Study coordinator (Luke Wood, Clinical Trial Coordinator) · luke.wood@mq.edu.au · +61 434 971 076
    Contact: Principal Investigator (Howard Gurney, Professor)

  • Beijing Cancer Hospital, Beijing, China

    Contact: Study coordinator (Jingjing Su) · jingjingsu@pharmaron.com · +86 02861508826
    Contact: Principal Investigator (Zhi Yang, Professor)
    Peng Du, MD (Sub-investigator)

  • Renji Shanghai Hospital, Shanghai, China

    Contact: Study coordinator (Vivien Hou) · vivienhou@pharmaron.com · +86 02861508826
    Contact: Principal Investigator (Wei Xu, MD)
    Contact: Principal Investigator (Jianjun Liu, MD)

  • Ankara Üniversitesi Tıp Fakültesi Cebeci Hastanesi Nükleer Tıp Anabilim Dalı, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Özlem Üstündag, Clinical Trial Coordinator) · ozlem_ustundag06@hotmail.com · +90 312 508 3879
    Contact: Principal Investigator (Yüksel Ürün)
Study leads

  • Full-Life Technologies GmbH

    Study Director

    Full-Life Technologies UK Limited

View source on ClinicalTrials.gov(opens in a new tab)